Edwards Lifesciences Corp reports results for the quarter ended June 30 - Earnings Summary

• Edwards Lifesciences Corp EW.N reported quarterly adjusted earnings of 67 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 70 cents. The mean expectation of twenty seven analysts for the quarter was for earnings of 62 cents per share. Wall Street expected results to range from 60 cents to 66 cents per share.

• Revenue fell 6.1% to $1.53 billion from a year ago; analysts expected $1.49 billion.

• Edwards Lifesciences Corp's reported EPS for the quarter was 56 cents​.

• The company reported quarterly net income of $333.2 million.

• Edwards Lifesciences Corp shares had fallen by 1.7% this quarter and gained 3.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy," 15 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Edwards Lifesciences Corp is $81.03, about 6.5% above its last closing price of $75.80

This summary was machine generated from LSEG data July 24 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)